fbpx
Site français à venir !
Give to the Unexpected | News From The Institute
Emergency Fund for Coronavirus Research

The Weizmann Institute of Science has launched an international $25 million Emergency Fund for Coronavirus Research to fast-track discoveries.

DONATE NOW AND BE PART OF THE COVID-19 SOLUTION

Every day, every individual on Earth is impacted by the current COVID-19 (coronavirus) pandemic.

Fortunately, every day more researchers around the world – including those at the Weizmann Institute – are dedicating their work to find answers. This effort is completely open science, with researchers donating their ideas and discoveries for the benefit of all globally.

Our Weizmann scientists, each from his or her own unique angle are urgently searching for answers and are making great headway. From finding the chemical targets of the coronavirus to lead to a possible drug to predicting where the coronavirus is and where it will spread worldwide, Weizmann researchers are collaborating with no boundaries.

With our world-renown research in immunology, structural biology, supercomputers and artificial intelligence, cellular sequencing, and drug discovery, in addition to the multidisciplinary and collaborative approach that we are known for, the Weizmann Institute is uniquely positioned to make a significant impact. Science gives us hope and science will have the answers. READ MORE

At this unprecedented time, we do understand that some people are themselves experiencing financial difficulties and may not be able to help. If you are able to support, donations can be made online.

DONATE NOW

 

 

Related Stories
Give to the Unexpected
Due to the popularity of our ‘Science speaks louder than words’ PPE masks (offered earlier this summer with donations to Weizmann COVID-19 research), we are now extending...
Newsletter, Give to the Unexpected
With the variety of ways donors can choose to give to a charity, Jamie Golombek with CIBC Financial Planning & Advice explains two ways how gifts of life insurance may be a strategic tax-effective option.